Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Seminars in Cancer Biology|December 29, 2011
Immunomodulating tellurium compounds as anti-cancer agentsBenjamin Sredni
Autoimmunity Reviews|August 26, 2014
The effect of the novel tellurium compound AS101 on autoimmune diseasesGilad Halpert, Benjamin Sredni
The Journal of Antimicrobial Chemotherapy|May 26, 2012
Bactericidal activity of the organo-tellurium compound AS101 against Enterobacter cloacaeMiriam Daniel-Hoffmann, Benjamin Sredni, Yeshayahu Nitzan
Journal of Hepatology|July 15, 2009
Resolution of inflammation-related apoptotic processes by the synthetic tellurium compound, AS101 following liver injuryMiri Brodsky, Shira Hirsh, Michael Albeck, et al.
Ultrasonics Sonochemistry|January 9, 2007
Characterization and activity of sonochemically-prepared BSA microspheres containing Taxol--an anticancer drugOlga Grinberg, Michal Hayun, Benjamin Sredni, et al.
Inorganic Chemistry|October 12, 2016
Ligand-Substitution Reactions of the Tellurium Compound AS-101 in Physiological Aqueous and Alcoholic SolutionsAlon Silberman, Michael Albeck, Benjamin Sredni, et al.
Archives of Microbiology|December 11, 2013
Antibacterial effects of the tellurium compound OTD on E. coli isolatesRina Yalew, Dvora Kenigsbuch-Sredni, Benjamin Sredni, et al.
Archives of Microbiology|June 17, 2009
A potential antimicrobial treatment against ESBL-producing Klebsiella pneumoniae using the tellurium compound AS101Miriam Daniel-Hoffmann, Michael Albeck, Benjamin Sredni, et al.
Pageof 6